Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Innovation Corridor Highlights Biotech Future

By Drug Discovery Trends Editor | June 2, 2008

Academics and industry leaders will showcase innovative ideas on the next groundbreaking technologies in the life sciences at the 2008 BIO International Convention’s Innovation Corridor poster sessions. Hosted by the Biotechnology Industry Organization (BIO), the global event for biotechnology will take place June 17-20 at the San Diego Convention Center in San Diego, Calif.

The Innovation Corridor will play host to presentations representing many different aspects of biotechnology and the life sciences including bioengineering, biologics, cancer, diagnostics, genomics, infectious disease, reproductive health, and stem cells.

“Participants in the Innovation Corridor represent the future of our industry,” said BIO President and CEO Jim Greenwood. “The ideas and concepts represented in their presentations will play an important role in the next generation of biotech therapies and applications

Innovation Corridor Poster Session winners will present their findings over the course of the convention. Winning presentations include:

  • Device to Prevent Contrast-Induced Kidney Failure presented by Paul Petrovich, University of Pittsburgh
  • Expanding Organ Donor Pool by “Ex Vivo Repair” with a Novel siRNA-Containing Organ Storage Solution presented by Wei-Ping Min, Lawson Health Research Institute
  • Click Chemistry: The Reach of a Few Good Reactions, presented by Valery Fokin, The Scripps Research Institute
  • Bacteriophage Amplification Technology: a platform for development of rapid antibiotic susceptibility tests, presented by Drew Smith, MicroPhage, Inc.
  • Rapid Diagnostic for CNS Ischemia due to Stroke, TIA, and TBI, presented by Allan Goldberg, Lesanne Life Sciences, LLC

View abstracts of the Innovation Corridor participants.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50